We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
-12.9%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$300M
AUM Growth
-$46.7M
Cap. Flow
+$2.3M
Cap. Flow %
0.77%
Top 10 Hldgs %
35.71%
Holding
205
New
3
Increased
58
Reduced
97
Closed
15

Sector Composition

Rank Sector Weight
1 Healthcare 22.07%
2 Technology 15.45%
3 Financials 11.09%
4 Industrials 9.33%
5 Communication Services 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
26
RTX Corp
RTX
$286B
$2.7M 0.9%
28,103
-490
-2% -$47.1K
PG icon
27
Procter & Gamble
PG
$332B
$2.64M 0.88%
18,372
-420
-2% -$63.1K
CEF icon
28
Sprott Physical Gold and Silver Trust
CEF
$7.36B
$2.58M 0.86%
153,487
-650
-0.4% -$11.8K
CNC icon
29
Centene
CNC
$30.1B
$2.54M 0.85%
30,022
-620
-2% -$51.5K
MTB icon
30
M&T Bank
MTB
$35.7B
$2.49M 0.83%
15,598
-242
-2% -$40.7K
VCSH icon
31
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.48M 0.83%
32,535
+21,346
+191% +$1.64M
XOM icon
32
ExxonMobil
XOM
$635B
$2.47M 0.82%
28,810
-1,612
-5% -$145K
TECH icon
33
Bio-Techne
TECH
$11.2B
$2.46M 0.82%
28,424
-228
-0.8% -$21.4K
AMGN icon
34
Amgen
AMGN
$205B
$2.38M 0.79%
9,801
-23
-0.2% -$5.64K
SBUX icon
35
Starbucks
SBUX
$122B
$2.38M 0.79%
31,162
-270
-0.9% -$20.7K
DGX icon
36
Quest Diagnostics
DGX
$25.8B
$2.36M 0.79%
17,737
-105
-0.6% -$14.3K
BND icon
37
Vanguard Total Bond Market
BND
$157B
$2.33M 0.78%
30,964
-14,990
-33% -$1.14M
CVS icon
38
CVS Health
CVS
$134B
$2.18M 0.73%
23,573
-300
-1% -$29.3K
WMT icon
39
Walmart Inc
WMT
$888B
$2.18M 0.73%
53,793
+54
+0.1% +$2.49K
GILD icon
40
Gilead Sciences
GILD
$161B
$2.17M 0.72%
35,060
-375
-1% -$23.2K
LIN icon
41
Linde
LIN
$221B
$2.16M 0.72%
7,515
MGV icon
42
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.1B
$2.16M 0.72%
22,434
-2,332
-9% -$239K
ANET icon
43
Arista Networks
ANET
$223B
$2.09M 0.7%
89,280
-3,600
-4% -$98.7K
VIG icon
44
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.08M 0.69%
14,518
+175
+1% +$26.6K
UNP icon
45
Union Pacific
UNP
$172B
$2.02M 0.67%
9,475
-160
-2% -$36.4K
VBR icon
46
Vanguard Morningstar Small-Cap Value ETF
VBR
$37B
$2.01M 0.67%
13,446
-1,529
-10% -$251K
CHRW icon
47
C.H. Robinson
CHRW
$17.4B
$2M 0.67%
19,764
-390
-2% -$40.7K
BDX icon
48
Becton Dickinson
BDX
$44.9B
$1.96M 0.65%
7,947
-57
-0.7% -$14.5K
KO icon
49
Coca-Cola
KO
$377B
$1.95M 0.65%
30,912
-330
-1% -$20.9K
VRTX icon
50
Vertex Pharmaceuticals
VRTX
$120B
$1.59M 0.53%
5,651
-390
-6% -$104K

Similar funds

Roberts, Glore & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Roberts, Glore & Co held 205 positions worth $300M, down 13% from $347M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Roberts, Glore & Co's Q2 2022 filing shows 3 new, 58 increased, 97 reduced and 15 closed positions. Its largest new stake was Vanguard Short-Term Inflation-Protected Securities Index Fund: 8,170 shares worth $409K. The largest sale was Vanguard Total Bond Market, an estimated $1.14M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q2 2022 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 8,170 shares worth $409K.
  • Roberts, Glore & Co added most to Vanguard Tax-Exempt Bond Index Fund in Q2 2022, an estimated $7.71M increase.
  • Roberts, Glore & Co's biggest Q2 2022 reduction was Vanguard Total Bond Market, cutting an estimated $1.14M.
  • Roberts, Glore & Co fully exited Vanguard Mortgage-Backed Securities ETF in Q2 2022, selling an estimated $1.13M.
  • Roberts, Glore & Co's ten largest holdings make up 36% of its $300M portfolio in Q2 2022.
  • Roberts, Glore & Co opened 3 new positions and closed 15 in Q2 2022.
  • Roberts, Glore & Co's portfolio value fell 13% quarter-over-quarter to $300M.

Based on Roberts, Glore & Co's 13F filing for Q2 2022, filed 11 Aug 2022.